secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2025-08-22T23:59:59+00:00
Accession:  0001708599-25-000101
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics amends bylaws to add safe harbor procedures and expand forum selection clause
--------------------------------------------------------------------------------

- Board adopted Bylaws Amendment on August 18, 2025, effective immediately.
- Adds safe harbor procedures for transactions involving interested directors, officers, or control groups.
- Expands forum selection clause to cover stockholder claims related to corporate business or governance.
- Amendment supplements Section 9.2 of the Amended and Restated Certificate of Incorporation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000170859925000101/0001708599-25-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000170859925000101/ser-20250818.htm
  HTML page:      https://secwatch.observer/filing/0001708599-25-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer